Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imidapril plus bisoprolol for hypertension with microalbuminuria
ChiCTR2400079781Phase 4Recruiting
- Sponsor
- Ruijin Hospital Ethics Committee
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in essential hypertension and Microalbuminuria comparing Imidapril monotherapy, Bisoprolol monotherapy and Imidapril plus bisoprolol combination (3 arms). Primary endpoints: Blood pressure, Urinary protein and 1 more. Started Jan 2024; status: recruiting.
02
Drugs
imidaprilbisoprolol
03
Conditions
essential hypertensionMicroalbuminuria
Beyond the preview
Go deeper on ChiCTR2400079781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079781.